TENAX THERAPEUTICS INC TENX
COM NEW · Common Stock · CUSIP 88032L605
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersChapel Hill, NC
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 3.4m as of 2024-10-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $6.19.
Trends to Q4 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2024 | 10 |
| Q2 2024 | 12 |
| Q3 2024 | 20 |
| Q4 2024 | 22 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 6 | 3 |
| Q3 2024 | 15 | 5 |
| Q4 2024 | 7 | 8 |
Biggest buyers
| JANUS HENDERSON GROUP PLC | New | +166.7k |
| MORGAN STANLEY | Added | +74.2k |
| MILLENNIUM MANAGEMENT LLC | New | +26.8k |
| VANGUARD GROUP INC | New | +22.3k |
| TWO SIGMA INVESTMENTS, LP | New | +13.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +6.0k |
| Physician Wealth Advisors, Inc. | New | +1 |
Biggest sellers
| Stonepine Capital Management, LLC | Sold out | -50.0k |
| SPHERA FUNDS MANAGEMENT LTD. | Sold out | -29.2k |
| Vestal Point Capital, LP | Reduced | -28.1k |
| ADAR1 Capital Management, LLC | Reduced | -27.7k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Sold out | -24.0k |
| Lynx1 Capital Management LP | Sold out | -14.8k |
| Tower Research Capital LLC (TRC) | Sold out | -1.7k |
| UBS Group AG | Reduced | -685 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| ADAR1 Capital Management, LLC 13G · institution new · filed 2026-09-08 | 14.0% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor no change · filed 2026-08-14 | 10.0% |
| JANUS HENDERSON GROUP PLC 13G · institution +6.0 pts · filed 2025-12-08 | 10.0% |
| RTW INVESTMENTS, LP 13G · institution no change · filed 2026-08-14 | 9.9% |
| Vestal Point Capital, LP 13G · institution new · filed 2025-11-14 | 9.9% |
| Vivo Opportunity Fund Holdings, L.P. 13G · passive investor filed 2026-08-14 | 9.0% |
| BlackRock, Inc. 13G · institution +1.1 pts · filed 2026-10-27 | 7.5% |
| SPHERA FUNDS MANAGEMENT LTD. 13G · passive investor +1.8 pts · filed 2026-10-13 | 7.1% |
| Adage Capital Management, L.P. 13G · institution filed 2026-08-12 | 6.8% |
| Dellora Investments LP 13G · passive investor +4.1 pts · filed 2026-10-09 | 6.4% |
Fell to 5% or below in the last year: MILLENNIUM MANAGEMENT LLC (3.6%, 2026-10-15), ING GROEP NV (0.0%, 2026-09-11), FMR LLC (1.4%, 2026-09-08), PERCEPTIVE ADVISORS LLC (4.5%, 2026-08-14), Venrock Healthcare Capital Partners III, L.P. (4.7%, 2026-08-14), Ikarian Capital, LLC (2.9%, 2026-08-14), Giordano Christopher Thomas (4.3%, 2026-07-31), PRICE T ROWE ASSOCIATES INC /MD/ (2.2%, 2026-06-05), Stonepine Capital Management, LLC (3.7%, 2026-05-15), Point72 Asset Management, L.P. (3.1%, 2026-05-15)
Insider purchases and sales in Q4 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 2 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
None reported in Q4 2024.
Holders, Q4 2024
| Manager | Shares | Change |
|---|---|---|
| BVF INC/IL 0.07% of their portfolio | 339.5k $2.1m | Unchanged |
| Venrock Adviser, LLC 0.09% of their portfolio | 208.3k $1.3m | Unchanged |
| Vivo Capital, LLC 0.14% of their portfolio | 208.3k $1.3m | Unchanged |
| JANUS HENDERSON GROUP PLC 0.00% of their portfolio | 166.7k $1.0m | New |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.00% of their portfolio | 83.3k $515.8k | Unchanged |
| Velan Capital Investment Management LP 0.45% of their portfolio | 83.3k $515.8k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 74.4k $460.8k | Added +74.2k |
| Vestal Point Capital, LP 0.02% of their portfolio | 55.2k $341.6k | Reduced -28.1k |
| ADAR1 Capital Management, LLC 0.04% of their portfolio | 34.7k $214.8k | Reduced -27.7k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 26.8k $165.9k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 24.4k $150.8k | Added +6.0k |
| VANGUARD GROUP INC 0.00% of their portfolio | 22.3k $138.0k | New |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 21.0k $130.0k | Unchanged |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 13.5k $83.7k | New |
| BlackRock, Inc. 0.00% of their portfolio | 300 $1.9k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 28 $173 | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 5 $31 | First filing |
| UBS Group AG 0.00% of their portfolio | 3 $18 | Reduced -685 |
| Allworth Financial LP 0.00% of their portfolio | 1 $7 | Unchanged |
| Union Bancaire Privee, UBP SA 0.00% of their portfolio | 1 $6 | First filing |
| Physician Wealth Advisors, Inc. 0.00% of their portfolio | 1 $7 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |